BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
89.27
-0.04 (-0.04%)
At close: Mar 20, 2026, 4:00 PM EDT
90.93
+1.66 (1.86%)
After-hours: Mar 20, 2026, 7:32 PM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $22.44 billion as of March 20, 2026. Its market cap has decreased by -15.56% in one year.
Market Cap
22.44B
Enterprise Value
6.62B
1-Year Change
-15.56%
Ranking
Category
Stock Price
$89.27
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $22.44B, an increase of 649.11%. That is a compound annual growth rate of 36.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 21.42B | -6.42% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alnylam Pharmaceuticals | 41.26B |
| BeOne Medicines AG | 31.34B |
| Insmed | 31.04B |
| Moderna | 20.68B |
| Roivant Sciences | 19.90B |
| Revolution Medicines | 19.68B |
| Royalty Pharma | 19.51B |
| Incyte | 18.50B |